Yingke Capital
VC Fund
Fuzhou, China
Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector. Yingke Capital prefers to invest in companies with high technology R&D and production capacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.
- Total investments:
- 104
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Yingke Capital invests in
Stages Yingke Capital invests in
Countries Yingke Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Series B
- $14M–$412M
- Series C
- $86k–$130M
- Venture - Series Unknown
- $1M–$672M
Investment Focus
Industry
- Health Care 26 (25%)
- Biotechnology 24 (23%)
- Manufacturing 23 (22%)
- Medical 19 (18%)
- Pharmaceutical 15 (14%)
Stage
- Series C 15 (14%)
- Venture - Series Unknown 15 (14%)
- Series B 14 (13%)
- Series A 13 (13%)
- Seed 11 (11%)
Country
- China 81 (78%)
- United States 5 (5%)
- Taiwan 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chen Yulei
Chief Investment Officer
|
Chief Investment Officer | Total investments: 1 | Find email | |
Manying Lai
President
|
President | Total investments: 0 | Find email | |
|
Shi Zhengzheng
Partner
|
Partner | Total investments: 2 | Find email | |
Shuqing Wu
President of Financial Division
|
President of Financial Division | Total investments: 0 | Find email | |
Xiaochen Zhou
Vice-President
|
Vice-President | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Sibo Medical
|
The primary aim of Sibo Medical's research and development is the creation of fully automated, magnetically controlled interventional surgical robots that are intended to treat cardiovascular and cerebrovascular conditions including stroke. | $14.9M / Seed / Sep 17, 2026 | |
|
Physen AI
|
Physen AI is a specialized physical interaction data infrastructure company focused on the embodied intelligence and robotics sector. | Angel / Jul 29, 2026 | |
| Listenai is an enterprise that provides AI chips and industry solutions for the field of artificial intelligence and the Internet of Things. | $73.7M / Series B / Jul 10, 2026 | ||
|
Vita Dynamics
|
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. | $73.6M / Seed / May 11, 2026 | |
| Yizhu Technology is a software company that specializes in AI computing power, engineering and consulting for storage data. | Venture - Series Unknown / Oct 29, 2025 | ||
|
Lingdong General
|
Lingdong General is a manufacturing company that provides research and development for industrial and service consumer robots. | Angel / Aug 12, 2025 | |
|
Vita Dynamics
|
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. | Angel / Aug 07, 2025 | |
Junde Pharmaceutical
|
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for thefull cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease. | $13.7M / Series A / Apr 18, 2025 | |
| WestGene Biopharma is a high-tech enterprise that focuses on the research and development, manufacturing and sales of mRNA therapeutics and adjuvants. | $41.8M / Series A / Jun 20, 2023 | ||
EnCureGen Pharmaceuticals
|
Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases. | Seed / Jun 08, 2023 | |
| See all 104 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Yingke Capital invest in?
Yingke Capital invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series C and Venture - Series Unknown stage. Most of the 104 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Yingke Capital invest in?
Yingke Capital typically joins rounds of $14M–$412M at Series B, $86k–$130M at Series C and $1M–$672M at Venture - Series Unknown. These are whole funding-round sizes, not Yingke Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yingke Capital took part in.
How do I contact Yingke Capital?
Public channels for Yingke Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Yingke Capital?
The team at Yingke Capital includes Chen Yulei (Chief Investment Officer), Manying Lai (President) and Shi Zhengzheng (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
